# Janssen Biotech, Inc. – FDA Inspection, Feb 27, 2017

Source: https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/351b5c60-a476-40a2-a8d9-bd8135ee2f6c
Source feed: FDA_Inspections

> FDA inspection 1007329 of Janssen Biotech, Inc., February 27, 2017. Classification: No Action Indicated (NAI). 14 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1007329
- Company Name: Janssen Biotech, Inc.
- Inspection Date: 2017-02-27
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1276933 - 2025-07-29](https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/0ecc31ca-e799-4909-bfc9-dcdfa484fbf5)
- FDA Inspection 1265723 - 2025-03-10
- FDA Inspection 1077487 - 2018-11-30
- [FDA Inspection 1046499 - 2018-03-05](https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/4135886d-b271-492a-8b05-81d78eba721b)
- [FDA Inspection 1031776 - 2017-11-21](https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/2f697eb7-fa9a-4da8-b845-2d83b13b09f0)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/james-p-mcevoy/3c374f77-2c97-4a74-ba01-969316d641ca)

Company: https://www.keypedia.com/companies/janssen-biotech-inc/5374365d-a0df-4a87-ad3d-2714628d3e57

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c